Atara Biotherapeutics, Inc. · NASDAQ:ATRA

Redmile Group, LLC reported a 9.90% stake in Atara Biotherapeutics, Inc. (Schedule 13D)

Event May 16, 2025 · Filed May 23, 2025

Redmile Group, LLC reported a 9.90% stake in Atara Biotherapeutics, Inc., 705,207 shares, with active intent on May 16, 2025. Filed May 23, 2025 (Schedule 13D).

Stake
9.90%
Shares
705,207
Intent
Active
What changed
Crossed above 5%
Filed together
4 holders

The filing in full

HolderStakeShares
Redmile Group, LLC9.90%705,207
Jeremy C. Green9.90%705,207
RedCo I, L.P.5.00%347,442
Redmile Biopharma Investments II, L.P.5.80%406,137

Source

View original at SEC

Related